The L1 adhesion molecule plays an important role in axon guidance and cell migration in the nervous system. L1 is also expressed by many human carcinomas. In addition to cell surface expression, the L1 ectodomain can be released by a metalloproteinase, but the biological function of this process is unknown. Here we demonstrate that membrane-proximal cleavage of L1 can be detected in tumors and in the developing mouse brain. The shedding of L1 involved a disintegrin and metalloproteinase (ADAM)10, as transfection with dominant-negative ADAM10 completely abolishes L1 release. L1-transfected CHO cells (L1-CHO) showed enhanced haptotactic migration on fibronectin and laminin, which was blocked by antibodies to αvβ5 and L1. Migration of L1-CHO cells, but not the basal migration of CHO cells, was blocked by a metalloproteinase inhibitor, indicating a role for L1 shedding in the migration process. CHO and metalloproteinase-inhibited L1-CHO cells were stimulated to migrate by soluble L1-Fc protein. The induction of migration was blocked by αvβ5-specific antibodies and required Arg-Gly-Asp sites in L1. A 150-kD L1 fragment released by plasmin could also stimulate CHO cell migration. We propose that ectodomain-released L1 promotes migration by autocrine/paracrine stimulation via αvβ5. This regulatory loop could be relevant for migratory processes under physiological and pathophysiological conditions.
Skip Nav Destination
Article navigation
12 November 2001
Article|
November 12 2001
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins
Sabine Mechtersheimer,
Sabine Mechtersheimer
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Paul Gutwein,
Paul Gutwein
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Nancy Agmon-Levin,
Nancy Agmon-Levin
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Alexander Stoeck,
Alexander Stoeck
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Matthias Oleszewski,
Matthias Oleszewski
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Svenja Riedle,
Svenja Riedle
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Rolf Postina,
Rolf Postina
4Institute of Biochemistry, University of Mainz, D-55128 Mainz, Germany
Search for other works by this author on:
Falk Fahrenholz,
Falk Fahrenholz
4Institute of Biochemistry, University of Mainz, D-55128 Mainz, Germany
Search for other works by this author on:
Mina Fogel,
Mina Fogel
2Department of Pathology, Kaplan Hospital, Rehovot 76100, Israel
Search for other works by this author on:
Vance Lemmon,
Vance Lemmon
3Department of Neurosciences, Case Western Reserve University, Cleveland, Ohio 44106
Search for other works by this author on:
Peter Altevogt
Peter Altevogt
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Sabine Mechtersheimer
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Paul Gutwein
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Nancy Agmon-Levin
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Alexander Stoeck
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Matthias Oleszewski
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Svenja Riedle
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Rolf Postina
4Institute of Biochemistry, University of Mainz, D-55128 Mainz, Germany
Falk Fahrenholz
4Institute of Biochemistry, University of Mainz, D-55128 Mainz, Germany
Mina Fogel
2Department of Pathology, Kaplan Hospital, Rehovot 76100, Israel
Vance Lemmon
3Department of Neurosciences, Case Western Reserve University, Cleveland, Ohio 44106
Peter Altevogt
1Tumor Immunology Program, G0100, German Cancer Research Center, D-69120 Heidelberg, Germany
Address correspondence to Peter Altevogt, Tumor Immunology Program, G0100, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. Tel.: 49-6221-423-714. Fax: 49-6221-423-702. E-mail: [email protected]
S. Mechtersheimer and P. Gutwein contributed equally to this work.
*
Abbreviations used in this paper: ADAM, a disintegrin and metalloproteinase; APP, amyloid precursor protein; AR, androgen receptor; FN, fibronectin; MCD, methyl-β-cyclodextrin; RGD, Arg-Gly-Asp.
Received:
January 29 2001
Revision Received:
October 02 2001
Accepted:
October 02 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2001
J Cell Biol (2001) 155 (4): 661–674.
Article history
Received:
January 29 2001
Revision Received:
October 02 2001
Accepted:
October 02 2001
Connected Content
This article has been corrected
Correction: Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins
Citation
Sabine Mechtersheimer, Paul Gutwein, Nancy Agmon-Levin, Alexander Stoeck, Matthias Oleszewski, Svenja Riedle, Rolf Postina, Falk Fahrenholz, Mina Fogel, Vance Lemmon, Peter Altevogt; Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins . J Cell Biol 12 November 2001; 155 (4): 661–674. doi: https://doi.org/10.1083/jcb.200101099
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement